|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.64 CHF | -0.41% |
|
+2.07% | +20.23% |
| 02:29am | AlphaValue/Baader Europe Ups Novartis Price Target on 'Strong' Execution, 'Vigorous' Growth | MT |
| 02:01am | NOVARTIS AG : Upgraded to Buy by JP Morgan | ZD |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 18.36x | 5.75x | 0.82x | 4.97x | 11.67x | 12.58x | 3.07% | 255B | ||
| 44.17x | 33.26x | 0.46x | 14.63x | 32.47x | 34.87x | 0.59% | 905B | ||
| 19.27x | 6.19x | 0.24x | 5.41x | 14.97x | 16.42x | 2.56% | 487B | ||
| 52.81x | -545.82x | 0.67x | 7.48x | 17.71x | 18.22x | 2.89% | 400B | ||
| 18.03x | 6.44x | 0.27x | 4.54x | 11.37x | 12.9x | 3.18% | 330B | ||
| 27.29x | 6.16x | 0.57x | 5.16x | 15.31x | 16.13x | 1.78% | 281B | ||
| 12.89x | 4.6x | 0.87x | 4.21x | 9x | 10.17x | 3.24% | 248B | ||
| 13.42x | 7.33x | 6.82x | 4.8x | 9.94x | 11.49x | 3.76% | 214B | ||
| 25.21x | 19.93x | 0.34x | 6.12x | 10.51x | 14.04x | 2.9% | 178B | ||
| 17.68x | 6.63x | 0.01x | 5.58x | 10.21x | 12.28x | 2.73% | 150B | ||
| 13.48x | 1.64x | 0.36x | 3.02x | 7.58x | 8.74x | 6.55% | 148B | ||
| 12.36x | 1.32x | 0.25x | 2.66x | 8.65x | 9.63x | 4.89% | 120B | ||
| 29.33x | 6.19x | -0.03x | 8.88x | 19.18x | 19.93x | -.--% | 116B | ||
| 12.32x | 5.36x | -0.06x | 2.91x | 8.45x | 8.81x | 4.74% | 106B | ||
| 12.89x | 5.05x | 0.11x | 2.67x | 7.87x | 9.02x | 3.6% | 96.56B | ||
| 31.62x | 6.88x | 2.98x | 10.19x | 19.94x | 21.32x | 3.08% | 87.18B | ||
| 200.41x | 72.37x | -0.98x | 15.74x | 103.92x | 100.59x | -.--% | 60.52B | ||
| 46.45x | 6.91x | 1.42x | 11.22x | 36.85x | 38.76x | 0.45% | 57.93B | ||
| 39.61x | 1.01x | 0.63x | 2.42x | 8.95x | 25.72x | 4.54% | 44.82B | ||
| Average | 34.08x | -18.04x | 0.83x | 6.45x | 19.19x | 21.14x | 2.87% | 225.47B | |
| Weighted average by Cap. | 30.51x | -38.47x | 0.79x | 7.48x | 18.47x | 20.08x | 2.5% |
- Stock Market
- Equities
- NOVN Stock
- Sector Novartis AG
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















